Edwards Lifesciences

Yahoo Finance • 2 months ago

Investors in Edwards Lifesciences (NYSE:EW) have unfortunately lost 41% over the last three years

Many investors define successful investing as beating the market average over the long term. But if you try your hand at stock picking, you risk returning less than the market. We regret to report that long term Edwards Lifesciences Corpor... Full story

Yahoo Finance • 3 months ago

ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM

NAPERVILLE, Ill., Sept. 28, 2024 /PRNewswire/ -- Endotronix, an Edwards Lifesciences company (NYSE: EW), today announced the one-year clinical results from PROACTIVE-HF, evaluating outcomes for the Cordella Pulmonary Artery (PA) Sensor Sys... Full story

Yahoo Finance • 3 months ago

We Think Edwards Lifesciences (NYSE:EW) Can Manage Its Debt With Ease

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. As with many other companies Edwards... Full story

Yahoo Finance • 4 months ago

David Rolfe's Strategic Moves in Edwards Lifesciences Corp Highlight Q2 2024 Investments

Insight into Wedgewood's Latest Portfolio Adjustments and Key Stock Performances David Rolfe (Trades, Portfolio), a seasoned portfolio manager with 18 years at the helm of Wedgewood's investments, has recently filed the 13F for the second... Full story

Yahoo Finance • 9 months ago

14 Best Medical Device Stocks To Buy Now

In this article, we will discuss the 14 Best Medical Device Stocks To Buy Now. You can skip our detailed analysis of the Medical Device Industry and go directly to the 5 Best Medical Device Stocks To Buy Now. The healthcare sector relies... Full story

Yahoo Finance • 10 months ago

25 Most Valuable Medical Device Companies in the US

In this article, we will be taking a look at the 25 most valuable medical device companies in the US. If you are not interested in learning about the emerging trend in medical device industry, head straight to the 5 Most Valuable Medical D... Full story

Yahoo Finance • 10 months ago

Edwards Lifesciences Corporation (NYSE:EW) Just Reported And Analysts Have Been Lifting Their Price Targets

Last week saw the newest full-year earnings release from Edwards Lifesciences Corporation (NYSE:EW), an important milestone in the company's journey to build a stronger business. Results were roughly in line with estimates, with revenues o... Full story

Yahoo Finance • 10 months ago

Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight

Edwards Lifesciences Corp (NYSE:EW) showcases robust market presence with innovative cardiovascular devices and a strong commitment to R&D. The company faces intense competition and regulatory challenges in a dynamic medical technology lan... Full story

Yahoo Finance • 10 months ago

Edwards Lifesciences Corp Director Heisz Stone Sells 7,056 Shares

On February 8, 2024, Heisz Stone, a director at Edwards Lifesciences Corp (NYSE:EW), sold 7,056 shares of the company. The transaction was filed with the SEC and can be found through the following SEC Filing. Edwards Lifesciences Corp is... Full story

Yahoo Finance • 10 months ago

Edwards Lifesciences' Fortunes Are Reaccelerating, Analyst Says — But Its Stock Isn't

There are signs Edwards' heart valve replacement technology is reaccelerating, an analyst said Wednesday. But EW stock only inched ahead. Continue reading... Full story

Yahoo Finance • 11 months ago

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

(Photo: Edwards Lifesciences) IRVINE, Calif., February 02, 2024--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to re... Full story

Yahoo Finance • 11 months ago

Edwards Lifesciences Corporation (EW) Fell in Q4 Despite Double-Digit Revenue Growth

Wedgewood Partners, an investment management company, released its fourth quarter 2023 investor letter. A copy of the same can be downloaded here. In the fourth quarter, Wedgewood Composite’s net return was 11.4% compared to the Standard &... Full story

Yahoo Finance • last year

Fears Of Negative Clinical Trial Result Dragged Edwards Lifesciences Corporation (EW) in Q3

Scout Investments, Inc, an affiliate of Carillon Tower Advisers, Inc, released the “Carillon Scout Mid Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. Major equity indices began the quarter on a pos... Full story

Yahoo Finance • last year

Some Confidence Is Lacking In Edwards Lifesciences Corporation's (NYSE:EW) P/E

With a price-to-earnings (or "P/E") ratio of 32.6x Edwards Lifesciences Corporation (NYSE:EW) may be sending very bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios under 16x and eve... Full story

Yahoo Finance • last year

S&P 500 Gains and Losses Today: AI Excitement Powers AMD, Alphabet

The S&P 500 added 0.8% on Thursday, Dec. 7, 2023, snapping a three-day losing streak amid excitement in the tech sector over new artificial intelligence (AI) products. Continue reading... Full story

Yahoo Finance • last year

Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference

IRVINE, Calif., December 07, 2023--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s sharpened focus and strategy for longer-term growth, provide an update on its technology pipeline and share financia... Full story

Yahoo Finance • last year

12 Best Medical Technology Stocks To Buy Now

In this article, we discuss 12 of the best medical device stocks to buy now. If you want to skip our detailed healthcare and medical technology industry discussion, head directly to the 5 Best Medical Technology Stocks To Buy Now. The med... Full story

Yahoo Finance • last year

Could Ozempic Harm These 3 Medical Device Stocks?

Ozempic, Novo Nordisk's (NYSE: NVO) blockbuster drug for type 2 diabetes, is having all sorts of unexpected impacts on the healthcare sector. With the help of similar medicines made by Eli Lilly (NYSE: LLY), and expanded labels that allow... Full story

Yahoo Finance • last year

TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION

SAN FRANCISCO, Oct. 26, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced successful results from TRISCEND II, a randomized controlled pivotal trial designed to evaluate the safety and effectiveness of the gr... Full story

Yahoo Finance • last year

Edwards Lifesciences Corporation (NYSE:EW) Q3 2023 Earnings Call Transcript

Edwards Lifesciences Corporation (NYSE:EW) Q3 2023 Earnings Call Transcript October 26, 2023 Operator: Greetings, and welcome to the Edwards Lifesciences Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a... Full story